MilliporeSigma, a subsidiary of Merck KGaA, opened a $317.2 million facility in Rockville in October of 2024. Located in the Alexandria Center at Traville Gateway, the 260,000-sf building provides advanced laboratories for biosafety testing, analytical development, viral clearance, and cell bank manufacturing. The project represents the company's largest investment to date in contract testing operations. Consolidating four separate lab buildings, the collaborative development was designed to drive innovation by fostering interaction between researchers. Advanced automation and digitalization technologies will increase throughput while ensuring stringent regulatory standards are met.
With wings dedicated to next-generation sequencing and molecular biology, the six-story facility features wall monitors that serve as digital windows, enabling clients to view the activities within. Over 800 of MilliporeSigma's employees are now based at this hub, which includes open office and meeting areas, as well as swing space to accommodate future growth. Alexandria Real Estate Equities was the developer for the project, which stands on a 12-acre greenfield site.
| Organization | Project Role |
|---|---|
|
Alexandria Real Estate Equities
|
Developer
|
